Filing Date |
T Date |
Ticker |
Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
#f |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
5/3/24 18:24 | 4/3/24 | RXRX | Health | BioPrd | Biological Products, (No Diag | Gibson Christopher | UT | DO | CEO | 4 | S.dm | -3,347 | 9.39 | 0 | -356 | 1,109 | M | |||||||||||||||
5/2/24 17:41 | 4/30/24 | RXRX | Health | BioPrd | Biological Products, (No Diag | Borgeson Blake | UT | D | 6 | S | -985 | 10.42 | 0 | -95 | 7,293 | D | ||||||||||||||||
4/29/24 18:41 | 2/22/24 | RXRX | Health | BioPrd | Biological Products, (No Diag | Marriott Tina | UT | O | P,COO | 3 | S.d | -228 | 12.01 | 0 | -19 | 640 | D | |||||||||||||||
4/18/24 17:12 | 4/16/24 | RXRX | Health | BioPrd | Biological Products, (No Diag | Secora Michael | UT | O | CFO | 2 | S.dm | -904 | 9.21 | 0 | -98 | 1,231 | D |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |